STELLA-FTD for Frontotemporal Dementia

(STELLA-FTD Trial)

Overseen By Hailey Chatterton, MS

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Oregon Health and Science University

Disqualifiers: Hearing, vision problems, hospice, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 8

640 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent video-conference based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the US.

Who Is on the Research Team?

Aimee Mooney, MA, CCC-SLP

Principal Investigator

Oregon Health and Science University

Allison Lindauer, PhD, APRN

Principal Investigator

Oregon Health and Science University

Are You a Good Fit for This Trial?

This trial is for family caregivers in the US who provide at least 4 hours of care per week to a relative with frontotemporal degeneration (FTD). They must identify at least two distressing behaviors in their relative, speak English, have an email and mailing address, and own a phone. The person with FTD they're caring for must also consent to participate.

Inclusion Criteria

I provide at least 4 hours of care per week.

I speak and understand English well enough to participate.

I am a family member who helps care for someone with a health condition.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

STELLA-FTD intervention delivered over 8 sessions within 10 consecutive weeks in 1-hour video-based group sessions

10 weeks

8 sessions (virtual)

Follow-up

Participants are monitored for safety and effectiveness after intervention

26 weeks

What Are the Treatments Tested in This Trial?

Interventions

• STELLA-FTD

Trial Overview STELLA-FTD is being tested; it's a video-conference based program designed to help caregivers manage behavioral symptoms of dementia by using community and peer resources effectively. Participants will be compared against a control group not receiving this specific intervention.

How Is the Trial Designed?

Group I: Test Group Experimental Treatment 1 Intervention

Test group, receives information and support in a group setting, but program is different from control (N=160 Care Partners).

Group II: Control Group Active Control 1 Intervention

Control group, receives information and support in a group setting (N=160 Care Partners).

Group III: Care Recipients with FTD Active Control 1 Intervention

Care recipients are consented to inform them of their rights, but they do not take part in any activities (N=320 Care Recipients).

Who Is Running the Clinical Trial?

Oregon Health and Science University

Lead Sponsor

Trials

1,024

Recruited

7,420,000+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+